Tal Medical, Inc. logo

Tal Medical, Inc.

Tal Medical is a clinical stage neuroscience company developing a non-invasive, rapid-acting neuromodulation therapy for depression, bipolar disorder and other psychiatric disorders.

Tal was founded by PureTech, in conjunction with leading scientists in the fields of neuromodulation and is developing a program for treating the dipression problems with a technology based on the work at McLean Hospital in Belmont, MA.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://talmedical.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
501 Boylston Street Suite 6102, MA 02116,USA,
Boston
United States
Email
Contact Number

Tal Medical is a clinical stage neuroscience company developing a non-invasive, rapid-acting neuromodulation therapy for depression, bipolar disorder and other psychiatric disorders.

Tal was founded by PureTech, in conjunction with leading scientists in the fields of neuromodulation and is developing a program for treating the dipression problems with a technology based on the work at McLean Hospital in Belmont, MA.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/tal-medical-inc-” connections=”true” suffix=””]

Tal Medical is developing a neurostimulation-based treatment, called Low Field Magnetic Stimulation (LFMS), derived from echo-planar magnetic resonance spectroscopic imaging technology. Low Field Magnetic Stimulation (LFMS) is the technology which is a non invassive technique that uses an external device to apply a pulsed magnetic field to the brain. In LFMS, the field strength is below the threshold required for neuronal firing.

In Apr 2015, Tal Medical secured $14 Mn funding round from existing investor PureTech, and several prominent individual investors. Prior this, inital seed funding was provided by PureTech Ventures.